Variant report
Variant | nsv527059 |
---|---|
Chromosome Location | chr2:49305933-49321164 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543828665 | chr2:49307419-49307420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs558513411 | chr2:49307426-49307427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs149170424 | chr2:49307471-49307472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs376405231 | chr2:49307472-49307473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs188437221 | chr2:49307480-49307481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559925149 | chr2:49307499-49307500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs527521519 | chr2:49307530-49307531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs2349712 | chr2:49307586-49307587 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs561063891 | chr2:49307617-49307618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs531289066 | chr2:49307652-49307653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs549814725 | chr2:49307678-49307679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs116363374 | chr2:49307695-49307696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs61343563 | chr2:49307730-49307731 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs146694475 | chr2:49307734-49307735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs181333179 | chr2:49307739-49307740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs186473367 | chr2:49307795-49307796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs548473788 | chr2:49307797-49307798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs570168488 | chr2:49307805-49307806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs374457314 | chr2:49307819-49307820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs79789760 | chr2:49307829-49307830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs57214069 | chr2:49307880-49307881 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs139247681 | chr2:49307886-49307887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs576785546 | chr2:49307898-49307899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs534688069 | chr2:49307925-49307926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs61127120 | chr2:49307948-49307949 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs73931522 | chr2:49308004-49308005 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs73931523 | chr2:49308025-49308026 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs560882978 | chr2:49308049-49308050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs576106829 | chr2:49308128-49308129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs547959065 | chr2:49308135-49308136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs543493147 | chr2:49308152-49308153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs564885517 | chr2:49308167-49308168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs141855404 | chr2:49308194-49308195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs559635612 | chr2:49308239-49308240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs190170357 | chr2:49308251-49308252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs530211485 | chr2:49308271-49308272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs560025164 | chr2:49308272-49308273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs530314509 | chr2:49308276-49308277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs548781197 | chr2:49308277-49308278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs570122979 | chr2:49308291-49308292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs372244380 | chr2:49308292-49308293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs147124825 | chr2:49308301-49308302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs375535557 | chr2:49308334-49308335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs181511656 | chr2:49308342-49308343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs570609033 | chr2:49308359-49308360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs534723672 | chr2:49308393-49308394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs531740644 | chr2:49308397-49308398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs145100372 | chr2:49308400-49308401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs534245360 | chr2:49319834-49319835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs58517784 | chr2:49319871-49319872 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:49307400-49308200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr2:49307400-49308200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr2:49307400-49308200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
4 | chr2:49307600-49308400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr2:49307800-49308200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr2:49308000-49308400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr2:49319800-49331800 | Weak transcription | Ovary | ovary |